Posted on by

Tesamorelin Clinical Evidence: Visceral Fat, Liver Health, and Metabolic Trials

3D render of a cell membrane receptor interacting with a peptide ligand to stimulate endocrine signaling.

A scientific review of clinical trial evidence evaluating tesamorelin, a growth hormone-releasing hormone analogue. We analyze human data on visceral adipo

Read more Tesamorelin Clinical Evidence: Visceral Fat, Liver Health, and Metabolic Trials

Posted on by

5-Amino-1MQ: Preclinical Evidence, Translational Hurdles, and Research Gaps

3D visualization of the NNMT enzyme catalytic site interacting with a small molecule inhibitor and cellular metabolites.

5-Amino-1MQ is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase studied for metabolic regulation and muscle physiology. While roden

Read more 5-Amino-1MQ: Preclinical Evidence, Translational Hurdles, and Research Gaps

Posted on by

TB-500 vs. Thymosin Beta-4: Structural Differences, Research Evidence, and Scientific Limitations

3D molecular visualization of an actin-binding peptide fragment interacting with actin protein filaments.

TB-500 and thymosin beta-4 are frequently conflated, yet they are distinct molecules. This scientific review examines their structural divergence, actin-bi

Read more TB-500 vs. Thymosin Beta-4: Structural Differences, Research Evidence, and Scientific Limitations

Posted on by

Survodutide Studies: Evaluating Dual GLP-1 and Glucagon Agonism in Clinical Research

3D scientific rendering of a dual agonist peptide binding to GLP-1 and glucagon cell surface receptors.

Survodutide is an investigational dual GLP-1 and glucagon receptor agonist undergoing clinical evaluation for obesity and metabolic dysfunction-associated

Read more Survodutide Studies: Evaluating Dual GLP-1 and Glucagon Agonism in Clinical Research